Grifols (0RDV) Price & Analysis
0RDV Stock Chart & Stats
€7.17€0.00(0.00%)
At close: 4:00 PM EDT
- Day’s Range
- EUR 7.17 - EUR 7.17
- 52-Week Range
- EUR 6.17 - EUR 8.20
- Previous Close
- EUR 7.17
- Volume
- 658
- Average Volume (3M)
- 15.11K
- Market Cap
- EUR 6.52B
- Enterprise Value
- EUR 14.73B
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- EUR 7.04B
- Price to Earnings (P/E)
- 10.8
- Beta
- 0.67
- Next Earnings
- Nov 02, 2026
- EPS Estimate
- 0.28
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 2.74%
0RDV FAQ
What was Grifols’s price range in the past 12 months?
Grifols lowest share price was €6.17 and its highest was €8.20 in the past 12 months.
What is Grifols’s market cap?
Grifols’s market cap is €6.52B.
When is Grifols’s upcoming earnings report date?
Grifols’s upcoming earnings report date is Nov 02, 2026 which is in 1 day.
How were Grifols’s earnings last quarter?
Grifols released its earnings results on Jul 28, 2026. The company reported €0.226 earnings per share for the quarter, missing the consensus estimate of €0.228 by -€0.002.
Is Grifols overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Grifols pay dividends?
Grifols does not currently pay dividends.
What is Grifols’s EPS estimate?
Grifols’s EPS estimate is 0.28.
How many shares outstanding does Grifols have?
Grifols has 261,425,100 shares outstanding.
What happened to Grifols’s price movement after its last earnings report?
Grifols reported an EPS of €0.226 in its last earnings report, missing expectations of €0.228. Following the earnings report the stock price went up 2.339%.
Which hedge fund is a major shareholder of Grifols?
Currently, no hedge funds are holding shares in GB:0RDV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Grifols Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Company Description
Grifols
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 78% of sales in 2019. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics is now roughly 14% of revenue following the Novartis and Hologic deals.
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- CEO
- Nacho Abia
- Employees
- 23,737
- Website
- www.grifols.com
- Address
- Avinguda de la Generalitat, 152-158,Parc de Negocis Can Sant Joan, Barcelona, 8174, ES
Grifols (0RDV) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 1 | 6 |
| Technical Analysis | 3 | 1 | 6 |
| Moving Averages | 12 | 0 | 0 |